Helen Assimakopoulos
About Helen Assimakopoulos
Helen Assimakopoulos is a Senior Clinical Site Manager at Bristol-Myers Squibb with over 25 years of experience in clinical site management.
Senior Clinical Site Manager at Bristol-Myers Squibb
Helen Assimakopoulos serves as a Senior Clinical Site Manager at Bristol-Myers Squibb. She holds a senior position within the company, highlighting her extensive experience in clinical site management. Helen is responsible for overseeing clinical trials and managing site operations, ensuring quality and compliance with regulatory standards. Her role is crucial in the successful execution of clinical trials, contributing significantly to the company's research and development efforts.
Over 25 Years at Bristol-Myers Squibb
Helen Assimakopoulos has been with Bristol-Myers Squibb for over 25 years, beginning her tenure in April 1998. Her long-standing career at the company underscores her dedication and expertise in the pharmaceutical industry. Throughout her time at Bristol-Myers Squibb, Helen has held various roles, culminating in her current position as Senior Clinical Site Manager.
Experience in Clinical Site Management
With a senior role in clinical site management, Helen Assimakopoulos brings extensive experience in overseeing clinical trials and site operations. Her responsibilities include coordinating with clinical staff, monitoring compliance with regulatory requirements, and ensuring the integrity of data collected during clinical studies. Helen's expertise ensures that clinical trials are conducted efficiently and in accordance with industry standards.
Clinical Operations in Canada
Based in Canada, Helen Assimakopoulos plays a vital role in Bristol-Myers Squibb's clinical operations within the region. Her work involves managing clinical sites across Canada, contributing to the development and execution of clinical trials. Helen's regional expertise ensures that the company's clinical trials are effectively administered, supporting Bristol-Myers Squibb's mission to discover and develop innovative medicines.